The dual mechanism may be advantageous for some patients but could also increase side-effect frequency or tolerability challenges in others
These approaches can be safely continued throughout the preconception period with appropriate professional guidance
If you take a GLP-1 medicine and have been hospitalised by acute pancreatitis, the Yellow Card Biobank wants to hear from you
Not dramatically differently, but the nuances matter
While traditional MCAS treatments can take months to show benefit, I've seen patients experience noticeable improvements in their most troublesome symptoms within 2-4 weeks of starting low-dose GLP-1 therapyexactly aligning with the rapid response times reported in the Afrin study
3,4 GLP-1RAs mimic the action of endogenous GLP-1, activating GLP-1R, thereby enhancing insulin secretion, inhibiting glucagon release, delaying gastric emptying, and reducing food intake through central appetite suppression